SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- Nektar Therapeutics
(Nasdaq: NKTR) today announced that its Chief Scientific Officer,
Jonathan Zalevsky, Ph.D., is
scheduled to present at the Cowen and Company 39th
Annual Health Care Conference on Tuesday,
March 12, 2019 at 9:20 a.m. Eastern
Time.
The presentation will be accessible via a webcast link posted on
the Investors section of the Nektar website at
http://ir.nektar.com/. This webcast will be available for replay
until April 12, 2019.
About Nektar
Nektar Therapeutics is a
research-based, development stage biopharmaceutical company whose
mission is to discover and develop innovative medicines to address
the unmet medical needs of patients. Our R&D pipeline of new
investigational medicines includes treatments for cancer,
auto-immune disease and chronic pain. We leverage our proprietary
and proven chemistry platform in the discovery and design of our
new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional
operations in Huntsville, Alabama and Hyderabad, India. Further information about
Nektar and its drug development programs and capabilities may be
found online at www.nektar.com.
View original
content:http://www.prnewswire.com/news-releases/nektar-therapeutics-to-webcast-presentation-at-the-cowen-and-company-39th-annual-health-care-conference-300807958.html
SOURCE Nektar Therapeutics